GB0015761D0 - Polypeptide - Google Patents
PolypeptideInfo
- Publication number
- GB0015761D0 GB0015761D0 GB0015761A GB0015761A GB0015761D0 GB 0015761 D0 GB0015761 D0 GB 0015761D0 GB 0015761 A GB0015761 A GB 0015761A GB 0015761 A GB0015761 A GB 0015761A GB 0015761 D0 GB0015761 D0 GB 0015761D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0015761A GB0015761D0 (en) | 2000-06-27 | 2000-06-27 | Polypeptide |
AU2001274344A AU2001274344A1 (en) | 2000-06-27 | 2001-06-27 | Tissue inhibitors of matrix metalloproteinases |
PCT/GB2001/002861 WO2002006480A2 (fr) | 2000-06-27 | 2001-06-27 | Inhibiteurs tissulaires de metalloproteinases matricielles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0015761A GB0015761D0 (en) | 2000-06-27 | 2000-06-27 | Polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0015761D0 true GB0015761D0 (en) | 2000-08-16 |
Family
ID=9894527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0015761A Ceased GB0015761D0 (en) | 2000-06-27 | 2000-06-27 | Polypeptide |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001274344A1 (fr) |
GB (1) | GB0015761D0 (fr) |
WO (1) | WO2002006480A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10138550A1 (de) * | 2001-08-06 | 2003-02-20 | Wolfgang E Berdel | Verwendung von TIMP-1 als Immunsuppressivum |
US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US10626399B2 (en) | 2010-01-28 | 2020-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
EP3079708A4 (fr) | 2013-12-09 | 2017-08-30 | The Board of Trustees of the Leland Stanford Junior University | Méthodes et compositions pour traiter des états associés au vieillissement |
CN113855804A (zh) | 2015-06-15 | 2021-12-31 | 小利兰·斯坦福大学托管委员会 | 用于治疗衰老相关病症的方法和组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU634533B2 (en) * | 1989-03-21 | 1993-02-25 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Matrix metalloproteinase inhibitor peptides |
WO1993013807A1 (fr) * | 1992-01-10 | 1993-07-22 | Georgetown University | Procede permettant d'administrer des cellules endotheliales produites par genie genetique au niveau de sites d'angiogenese afin d'effectuer une therapie genetique |
US6562596B1 (en) * | 1993-10-06 | 2003-05-13 | Amgen Inc. | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
JPH1017492A (ja) * | 1996-07-02 | 1998-01-20 | Fuji Yakuhin Kogyo Kk | 腫瘍細胞増殖抑制剤 |
DE19850986A1 (de) * | 1998-11-05 | 2000-05-25 | Aventis Pharma Gmbh | Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen |
-
2000
- 2000-06-27 GB GB0015761A patent/GB0015761D0/en not_active Ceased
-
2001
- 2001-06-27 AU AU2001274344A patent/AU2001274344A1/en not_active Abandoned
- 2001-06-27 WO PCT/GB2001/002861 patent/WO2002006480A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002006480A3 (fr) | 2004-02-26 |
WO2002006480A2 (fr) | 2002-01-24 |
AU2001274344A1 (en) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0014870D0 (en) | Peptides | |
AU8441801A (en) | Novel polypeptide | |
GB0029777D0 (en) | Peptides | |
GB0015761D0 (en) | Polypeptide | |
GB0127017D0 (en) | New polypeptide | |
GB0001825D0 (en) | Peptides | |
GB0120704D0 (en) | Polypeptide | |
GB0124559D0 (en) | New polypeptide | |
GB0127028D0 (en) | New polypeptide | |
EP1354947A4 (fr) | Nouveau polypeptide | |
GB0018307D0 (en) | Polypeptides | |
GB0013239D0 (en) | Polypeptide | |
GB0007263D0 (en) | Peptides | |
EP1179592A4 (fr) | Proteines du type nectine 3 | |
GB0012199D0 (en) | New polypeptide | |
GB0030293D0 (en) | Polypeptide | |
GB0010170D0 (en) | Polypeptide | |
GB0027166D0 (en) | Polypeptide | |
GB0023444D0 (en) | Polypeptide | |
GB0021524D0 (en) | Polypeptide | |
GB0019861D0 (en) | Polypeptide | |
GB0109286D0 (en) | New polypeptide | |
GB0030501D0 (en) | New polypeptide | |
GB0024445D0 (en) | New polypeptide | |
GB0019859D0 (en) | New polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |